Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Tumor Mutational Burden, Precision Immunotherapy

Razelle Kurzrock

MD

🏢Medical College of Wisconsin🌐USA

Professor

72
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Razelle Kurzrock is a leading precision oncology pioneer whose research on tumor mutational burden as a pan-cancer immunotherapy biomarker has been highly influential. She has led Phase 2 basket trial programs evaluating immunotherapy in TMB-high tumors across multiple histologies. Her work on molecular tumor boards and biomarker-matched therapy has advanced personalized cancer treatment. She continues to push the boundaries of early-phase precision immunotherapy trials at the Medical College of Wisconsin.

Share:

🧪Research Fields 研究领域

TMB pancancer
precision immunotherapy
molecular tumor boards
biomarker-driven trials
early phase clinical trials oncology

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Razelle Kurzrock 的研究动态

Follow Razelle Kurzrock's research updates

留下邮箱,当我们发布与 Razelle Kurzrock(Medical College of Wisconsin)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment